PALS in the News:
September 2017- Treatment with a GLP−1R agonist over four weeks promotes weight loss-moderated changes in frontal-striatal brain structures in individuals with
mood disorders, published in European Neuropsychopharmacology.
Click here to access the full paper!
Introducing Dr. Teresa Seeman from the David Geffen School of Medicine at UCLA, the
newest member of PALS!
April 2017, New York, NY: Mechanisms of Insulin Resistance in the CNS and Periphery Workshop funded by the NIDDK.
Catherine Lord @WeillCornell & Matthew State @UCSF receive Sarnat Prize in Mental Health for their work on autism:… twitter.com/i/web/status/9…
Recommend this page on:
Web ViewMobile View